Altimmune Inc (ALT)
$6.74
0.00 (0.00%)
ALT Stock Quote Delayed 30 Minutes
The 3 Smartest Biotech Stocks to Buy With $5K Right Now
With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
477.88M
PE Ratio
-4.19
EPS
-1.61
Volume (Avg. Vol.)
320
Day's Range
-
52-Week Range
$2.09 - $14.84
Dividend & Yield
N/A (N/A)
ALT Stock Predictions, Articles, and Altimmune Inc News
ALT Stock Earnings: Altimmune Beats EPS for Q1 2024
ALT stock results show that Altimmune beat analyst estimates for earnings per share the first quarter of 2024.
ALT Stock Earnings: Altimmune Beats EPS for Q4 2023
ALT stock results show that Altimmune beat analyst estimates for earnings per share the fourth quarter of 2023.
Why Is Altimmune (ALT) Stock Up 14% Today?
Altimmune stock is rising higher on Monday as ALT investors react to positive news from rival weight loss drugmaker Zealand Pharma.
Kerrisdale Capital Slams Altimmune (ALT) Stock in New Short Report
Kerrisdale Capital has released a short report, making clear why it is betting against ALT stock. Here's why Altimmune is likely in trouble.
Why Is Altimmune (ALT) Stock Up 43% Today?
Altimmune stock is rising higher on Friday with heavy trading of ALT shares after posting positive results form a clinical trial.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers on Friday morning!
Why Is Altimmune (ALT) Stock Down 67% Today?
Altimmune (ALT) stock is losing value on Tuesday after the company released results from a Phase 2 clinical trial for obesity.
